HEADER TRANSFERASE 25-MAY-18 6GMG TITLE STRUCTURE OF A GLUTAMINE DONOR MIMICKING INHIBITORY PEPTIDE SHAPED BY TITLE 2 THE CATALYTIC CLEFT OF MICROBIAL TRANSGLUTAMINASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: PAPAIN INHIBITOR; COMPND 6 CHAIN: C, D; COMPND 7 SYNONYM: SPI; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: CHLOROACETYLATED SERINE PEPTIDE DERIVED FROM SPI AA1- COMPND 10 10, GLUTAMIN6 WAS REPLACE BY A CHLOROACETYLATED SERINE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES MOBARAENSIS NBRC 13819 = DSM SOURCE 3 40847; SOURCE 4 ORGANISM_TAXID: 1223523; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 ORGANISM_SCIENTIFIC: STREPTOMYCES MOBARAENSIS; SOURCE 8 ORGANISM_COMMON: STREPTOVERTICILLIUM MOBARAENSE; SOURCE 9 ORGANISM_TAXID: 35621 KEYWDS TRANSGLUTAMINASE ; STREPTOMYCES MOBARAENSIS ; PEPTIDIC INHIBITORS; KEYWDS 2 ENZYME PEPTIDE INTERACTION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SCHMELZ,N.E.JUETTNER,H.L.FUCHSBAUER,A.SCRIMA REVDAT 4 06-NOV-24 6GMG 1 REMARK REVDAT 3 17-JAN-24 6GMG 1 REMARK REVDAT 2 26-DEC-18 6GMG 1 JRNL REVDAT 1 24-OCT-18 6GMG 0 JRNL AUTH N.E.JUETTNER,S.SCHMELZ,A.KRAEMER,S.KNAPP,B.BECKER,H.KOLMAR, JRNL AUTH 2 A.SCRIMA,H.L.FUCHSBAUER JRNL TITL STRUCTURE OF A GLUTAMINE DONOR MIMICKING INHIBITORY PEPTIDE JRNL TITL 2 SHAPED BY THE CATALYTIC CLEFT OF MICROBIAL TRANSGLUTAMINASE. JRNL REF FEBS J. V. 285 4684 2018 JRNL REFN ISSN 1742-4658 JRNL PMID 30318745 JRNL DOI 10.1111/FEBS.14678 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_3112 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 35047 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.278 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0110 - 5.2883 0.99 2646 140 0.1988 0.2453 REMARK 3 2 5.2883 - 4.1983 0.99 2595 137 0.1740 0.1995 REMARK 3 3 4.1983 - 3.6679 0.99 2597 137 0.1829 0.2454 REMARK 3 4 3.6679 - 3.3326 0.99 2564 135 0.2089 0.2938 REMARK 3 5 3.3326 - 3.0938 0.99 2563 135 0.2447 0.2770 REMARK 3 6 3.0938 - 2.9114 0.99 2551 134 0.2426 0.2976 REMARK 3 7 2.9114 - 2.7656 0.99 2560 135 0.2493 0.3157 REMARK 3 8 2.7656 - 2.6452 0.99 2548 135 0.2482 0.2850 REMARK 3 9 2.6452 - 2.5434 0.99 2550 134 0.2561 0.3451 REMARK 3 10 2.5434 - 2.4557 0.98 2546 134 0.2683 0.3570 REMARK 3 11 2.4557 - 2.3789 0.98 2528 132 0.2730 0.2990 REMARK 3 12 2.3789 - 2.3109 0.98 2536 134 0.2619 0.3435 REMARK 3 13 2.3109 - 2.2500 0.98 2509 132 0.2695 0.3345 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6GMG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1200010210. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS BUILT=20180126 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.1 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35089 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.19600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.90200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.7.18 REMARK 200 STARTING MODEL: 1IU4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 38% V/V PEG400, 70 MM DI-SODIUM REMARK 280 HYDROGEN PHOSPHATE, 100 MM SODIUM PHOSPHATE CITRATE, PH 4.4, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 292.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.74600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP B 1 REMARK 465 THR C 9 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 1 CG OD1 OD2 REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 LYS A 95 CG CD CE NZ REMARK 470 ARG B 98 CG CD NE CZ NH1 NH2 REMARK 470 ASP D 1 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 3 31.09 -79.01 REMARK 500 ASN A 96 -31.60 -134.13 REMARK 500 SER A 101 94.30 -66.26 REMARK 500 ALA A 261 51.07 -149.93 REMARK 500 ALA A 280 70.72 -150.98 REMARK 500 ASP B 3 45.15 -81.22 REMARK 500 ARG B 100 -169.58 -79.68 REMARK 500 HIS B 188 19.53 59.10 REMARK 500 ALA B 261 61.89 -153.50 REMARK 500 MET D 8 22.39 -79.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FLC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PEG B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLY C 5 and OAS C 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OAS C 6 and LYS C 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide GLY D 5 and OAS D 6 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide OAS D 6 and LYS D 7 DBREF 6GMG A 1 331 UNP M3C567 M3C567_STRMB 55 385 DBREF 6GMG B 1 331 UNP M3C567 M3C567_STRMB 55 385 DBREF 6GMG C 1 9 PDB 6GMG 6GMG 1 9 DBREF 6GMG D 1 9 PDB 6GMG 6GMG 1 9 SEQRES 1 A 331 ASP SER ASP ASP ARG VAL THR PRO PRO ALA GLU PRO LEU SEQRES 2 A 331 ASP ARG MET PRO ASP PRO TYR ARG PRO SER TYR GLY ARG SEQRES 3 A 331 ALA GLU THR VAL VAL ASN ASN TYR ILE ARG LYS TRP GLN SEQRES 4 A 331 GLN VAL TYR SER HIS ARG ASP GLY ARG LYS GLN GLN MET SEQRES 5 A 331 THR GLU GLU GLN ARG GLU TRP LEU SER TYR GLY CYS VAL SEQRES 6 A 331 GLY VAL THR TRP VAL ASN SER GLY GLN TYR PRO THR ASN SEQRES 7 A 331 ARG LEU ALA PHE ALA SER PHE ASP GLU ASP ARG PHE LYS SEQRES 8 A 331 ASN GLU LEU LYS ASN GLY ARG PRO ARG SER GLY GLU THR SEQRES 9 A 331 ARG ALA GLU PHE GLU GLY ARG VAL ALA LYS GLU SER PHE SEQRES 10 A 331 ASP GLU GLU LYS GLY PHE GLN ARG ALA ARG GLU VAL ALA SEQRES 11 A 331 SER VAL MET ASN ARG ALA LEU GLU ASN ALA HIS ASP GLU SEQRES 12 A 331 SER ALA TYR LEU ASP ASN LEU LYS LYS GLU LEU ALA ASN SEQRES 13 A 331 GLY ASN ASP ALA LEU ARG ASN GLU ASP ALA ARG SER PRO SEQRES 14 A 331 PHE TYR SER ALA LEU ARG ASN THR PRO SER PHE LYS GLU SEQRES 15 A 331 ARG ASN GLY GLY ASN HIS ASP PRO SER ARG MET LYS ALA SEQRES 16 A 331 VAL ILE TYR SER LYS HIS PHE TRP SER GLY GLN ASP ARG SEQRES 17 A 331 SER SER SER ALA ASP LYS ARG LYS TYR GLY ASP PRO ASP SEQRES 18 A 331 ALA PHE ARG PRO ALA PRO GLY THR GLY LEU VAL ASP MET SEQRES 19 A 331 SER ARG ASP ARG ASN ILE PRO ARG SER PRO THR SER PRO SEQRES 20 A 331 GLY GLU GLY PHE VAL ASN PHE ASP TYR GLY TRP PHE GLY SEQRES 21 A 331 ALA GLN THR GLU ALA ASP ALA ASP LYS THR VAL TRP THR SEQRES 22 A 331 HIS GLY ASN HIS TYR HIS ALA PRO ASN GLY SER LEU GLY SEQRES 23 A 331 ALA MET HIS VAL TYR GLU SER LYS PHE ARG ASN TRP SER SEQRES 24 A 331 GLU GLY TYR SER ASP PHE ASP ARG GLY ALA TYR VAL ILE SEQRES 25 A 331 THR PHE ILE PRO LYS SER TRP ASN THR ALA PRO ASP LYS SEQRES 26 A 331 VAL LYS GLN GLY TRP PRO SEQRES 1 B 331 ASP SER ASP ASP ARG VAL THR PRO PRO ALA GLU PRO LEU SEQRES 2 B 331 ASP ARG MET PRO ASP PRO TYR ARG PRO SER TYR GLY ARG SEQRES 3 B 331 ALA GLU THR VAL VAL ASN ASN TYR ILE ARG LYS TRP GLN SEQRES 4 B 331 GLN VAL TYR SER HIS ARG ASP GLY ARG LYS GLN GLN MET SEQRES 5 B 331 THR GLU GLU GLN ARG GLU TRP LEU SER TYR GLY CYS VAL SEQRES 6 B 331 GLY VAL THR TRP VAL ASN SER GLY GLN TYR PRO THR ASN SEQRES 7 B 331 ARG LEU ALA PHE ALA SER PHE ASP GLU ASP ARG PHE LYS SEQRES 8 B 331 ASN GLU LEU LYS ASN GLY ARG PRO ARG SER GLY GLU THR SEQRES 9 B 331 ARG ALA GLU PHE GLU GLY ARG VAL ALA LYS GLU SER PHE SEQRES 10 B 331 ASP GLU GLU LYS GLY PHE GLN ARG ALA ARG GLU VAL ALA SEQRES 11 B 331 SER VAL MET ASN ARG ALA LEU GLU ASN ALA HIS ASP GLU SEQRES 12 B 331 SER ALA TYR LEU ASP ASN LEU LYS LYS GLU LEU ALA ASN SEQRES 13 B 331 GLY ASN ASP ALA LEU ARG ASN GLU ASP ALA ARG SER PRO SEQRES 14 B 331 PHE TYR SER ALA LEU ARG ASN THR PRO SER PHE LYS GLU SEQRES 15 B 331 ARG ASN GLY GLY ASN HIS ASP PRO SER ARG MET LYS ALA SEQRES 16 B 331 VAL ILE TYR SER LYS HIS PHE TRP SER GLY GLN ASP ARG SEQRES 17 B 331 SER SER SER ALA ASP LYS ARG LYS TYR GLY ASP PRO ASP SEQRES 18 B 331 ALA PHE ARG PRO ALA PRO GLY THR GLY LEU VAL ASP MET SEQRES 19 B 331 SER ARG ASP ARG ASN ILE PRO ARG SER PRO THR SER PRO SEQRES 20 B 331 GLY GLU GLY PHE VAL ASN PHE ASP TYR GLY TRP PHE GLY SEQRES 21 B 331 ALA GLN THR GLU ALA ASP ALA ASP LYS THR VAL TRP THR SEQRES 22 B 331 HIS GLY ASN HIS TYR HIS ALA PRO ASN GLY SER LEU GLY SEQRES 23 B 331 ALA MET HIS VAL TYR GLU SER LYS PHE ARG ASN TRP SER SEQRES 24 B 331 GLU GLY TYR SER ASP PHE ASP ARG GLY ALA TYR VAL ILE SEQRES 25 B 331 THR PHE ILE PRO LYS SER TRP ASN THR ALA PRO ASP LYS SEQRES 26 B 331 VAL LYS GLN GLY TRP PRO SEQRES 1 C 9 ASP ILE PRO ILE GLY OAS LYS MET THR SEQRES 1 D 9 ASP ILE PRO ILE GLY OAS LYS MET THR HET OAS C 6 9 HET OAS D 6 9 HET FLC A 401 13 HET PEG A 402 7 HET PEG A 403 7 HET PEG B 401 7 HET PEG B 402 7 HET PEG B 403 7 HETNAM OAS O-ACETYLSERINE HETNAM FLC CITRATE ANION HETNAM PEG DI(HYDROXYETHYL)ETHER FORMUL 3 OAS 2(C5 H9 N O4) FORMUL 5 FLC C6 H5 O7 3- FORMUL 6 PEG 5(C4 H10 O3) FORMUL 11 HOH *277(H2 O) HELIX 1 AA1 VAL A 31 TYR A 42 1 12 HELIX 2 AA2 THR A 53 SER A 61 1 9 HELIX 3 AA3 GLY A 63 GLY A 73 1 11 HELIX 4 AA4 ASP A 86 GLY A 97 1 12 HELIX 5 AA5 THR A 104 SER A 116 1 13 HELIX 6 AA6 ASP A 118 GLU A 138 1 21 HELIX 7 AA7 ASP A 142 GLY A 157 1 16 HELIX 8 AA8 ASP A 159 GLU A 164 5 6 HELIX 9 AA9 THR A 177 GLU A 182 1 6 HELIX 10 AB1 ASP A 189 SER A 191 5 3 HELIX 11 AB2 SER A 211 GLY A 218 1 8 HELIX 12 AB3 ASP A 266 LYS A 269 5 4 HELIX 13 AB4 PHE A 295 GLU A 300 1 6 HELIX 14 AB5 VAL B 31 TYR B 42 1 12 HELIX 15 AB6 THR B 53 SER B 61 1 9 HELIX 16 AB7 GLY B 63 GLY B 73 1 11 HELIX 17 AB8 ASP B 86 ASN B 96 1 11 HELIX 18 AB9 THR B 104 SER B 116 1 13 HELIX 19 AC1 ASP B 118 GLU B 138 1 21 HELIX 20 AC2 ASP B 142 GLY B 157 1 16 HELIX 21 AC3 ASP B 159 GLU B 164 5 6 HELIX 22 AC4 THR B 177 GLU B 182 1 6 HELIX 23 AC5 ASP B 189 SER B 191 5 3 HELIX 24 AC6 SER B 211 GLY B 218 1 8 HELIX 25 AC7 ASP B 233 ASP B 237 5 5 HELIX 26 AC8 ASP B 266 LYS B 269 5 4 HELIX 27 AC9 PHE B 295 GLY B 301 1 7 SHEET 1 AA1 3 ARG A 26 VAL A 30 0 SHEET 2 AA1 3 HIS A 289 LYS A 294 -1 O GLU A 292 N ALA A 27 SHEET 3 AA1 3 VAL A 271 GLY A 275 -1 N HIS A 274 O TYR A 291 SHEET 1 AA2 4 ALA A 81 PHE A 82 0 SHEET 2 AA2 4 ARG A 307 PRO A 316 -1 O TYR A 310 N PHE A 82 SHEET 3 AA2 4 MET A 193 PHE A 202 -1 N VAL A 196 O THR A 313 SHEET 4 AA2 4 PHE A 254 GLY A 260 -1 O GLY A 257 N SER A 199 SHEET 1 AA3 3 ARG B 26 VAL B 30 0 SHEET 2 AA3 3 HIS B 289 LYS B 294 -1 O GLU B 292 N ALA B 27 SHEET 3 AA3 3 VAL B 271 GLY B 275 -1 N HIS B 274 O TYR B 291 SHEET 1 AA4 4 ALA B 81 PHE B 82 0 SHEET 2 AA4 4 ARG B 307 PRO B 316 -1 O TYR B 310 N PHE B 82 SHEET 3 AA4 4 MET B 193 PHE B 202 -1 N TYR B 198 O VAL B 311 SHEET 4 AA4 4 ASP B 255 GLY B 260 -1 O GLY B 257 N SER B 199 LINK SG CYS A 64 C2A OAS C 6 1555 1555 1.77 LINK SG CYS B 64 C2A OAS D 6 1555 1555 1.77 LINK C GLY C 5 N OAS C 6 1555 1555 1.33 LINK C OAS C 6 N LYS C 7 1555 1555 1.33 LINK C GLY D 5 N OAS D 6 1555 1555 1.33 LINK C OAS D 6 N LYS D 7 1555 1555 1.33 CISPEP 1 TRP A 330 PRO A 331 0 -1.62 CISPEP 2 TRP B 330 PRO B 331 0 -3.80 SITE 1 AC1 8 ARG A 79 ASN A 176 HOH A 586 ARG B 79 SITE 2 AC1 8 ARG B 167 SER B 172 ARG B 175 ASN B 176 SITE 1 AC2 2 ASP A 255 TYR A 302 SITE 1 AC3 7 TRP A 38 SER A 43 ARG A 45 GLN A 56 SITE 2 AC3 7 VAL A 70 GLY A 73 TRP A 319 SITE 1 AC4 3 VAL B 252 ASN B 276 TYR B 302 SITE 1 AC5 7 TRP B 38 SER B 43 ARG B 45 GLN B 56 SITE 2 AC5 7 VAL B 70 GLY B 73 TRP B 319 SITE 1 AC6 7 GLY B 110 LYS B 114 TRP B 203 TYR B 217 SITE 2 AC6 7 ARG B 242 ASP B 306 HOH B 587 SITE 1 AC7 11 TYR A 62 CYS A 64 VAL A 252 PHE A 254 SITE 2 AC7 11 ASP A 255 ASN A 276 HIS A 277 TYR A 278 SITE 3 AC7 11 HOH A 554 ILE C 4 LYS C 7 SITE 1 AC8 13 ASP A 3 CYS A 64 VAL A 252 PHE A 254 SITE 2 AC8 13 ASP A 255 ASN A 276 HIS A 277 TYR A 278 SITE 3 AC8 13 LEU A 285 HOH A 554 ILE C 4 GLY C 5 SITE 4 AC8 13 MET C 8 SITE 1 AC9 11 GLY B 63 CYS B 64 VAL B 252 PHE B 254 SITE 2 AC9 11 GLY B 275 ASN B 276 HIS B 277 TYR B 278 SITE 3 AC9 11 PRO D 3 ILE D 4 LYS D 7 SITE 1 AD1 12 GLY B 63 CYS B 64 VAL B 252 PHE B 254 SITE 2 AD1 12 GLY B 275 ASN B 276 HIS B 277 LEU B 285 SITE 3 AD1 12 ILE D 4 GLY D 5 MET D 8 THR D 9 CRYST1 60.525 85.492 78.793 90.00 111.62 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016522 0.000000 0.006548 0.00000 SCALE2 0.000000 0.011697 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013652 0.00000